secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eledon Pharmaceuticals, Inc. (ELDN)
CIK:        0001404281
Form:       8-K
Filed at:   2024-07-10T23:59:59+00:00
Accession:  0000950170-24-082730
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eledon shareholders approve 3.5M share increase to 2020 incentive plan; director Ogier retires, committees reshuffled
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2020 Long Term Incentive Plan, increasing share reserve by 3.5M to 17.96M shares and extending grant period to May 2034.
- Class I directors Steven Perrin and June Lee elected to three-year terms with 18.4M and 17.3M votes for, respectively.
- Walter Ogier retired from board effective July 10; Audit, Compensation, and Nominating committees restructured with new members.
- KMJ Corbin & Company LLP ratified as independent auditor for fiscal 2024 with 23.1M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024082730/0000950170-24-082730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404281/000095017024082730/eldn-20240710.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-082730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer